tiprankstipranks
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market
Holding ATHA?
Track your performance easily

Athira Pharma (ATHA) Technical Analysis

543 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Athira Pharma’s (ATHA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Athira Pharma is a Sell.
Athira Pharma’s (ATHA) 20-Day exponential moving average is 0.64, while Athira Pharma’s (ATHA) share price is $0.627, making it a Sell.
Athira Pharma’s (ATHA) 50-Day exponential moving average is 0.81, while Athira Pharma’s (ATHA) share price is $0.627, making it a Sell.

Athira Pharma (ATHA) Pivot Points

Nov 26, 2024, 05:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.60
0.61
0.63
0.64
0.66
0.67
0.69
Fibonacci
0.61
0.63
0.63
0.64
0.66
0.66
0.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Athira Pharma (ATHA) Moving Averages

Nov 26, 2024, 05:07 PM
Period
Simple
Exponential
MA5
0.64Sell
0.65Sell
MA10
0.68Sell
0.65Sell
MA20
0.64Sell
0.64Sell
MA50
0.53Buy
0.81Sell
MA100
1.62Sell
1.27Sell
MA200
2.14Sell
1.82Sell
Athira Pharma’s (ATHA) 10-Day exponential moving average is 0.65, while Athira Pharma’s (ATHA) share price is $0.627, making it a Sell.
Athira Pharma’s (ATHA) 100-Day exponential moving average is 1.27, while Athira Pharma’s (ATHA) share price is $0.627, making it a Sell.
Athira Pharma’s (ATHA) stock price is $0.627 and Athira Pharma’s (ATHA) 50-day simple moving average is 0.53, creating a Buy signal.
Athira Pharma’s (ATHA) stock price is $0.627 and Athira Pharma’s (ATHA) 100-day simple moving average is 1.62, creating a Sell signal.
Athira Pharma’s (ATHA) stock price is $0.627 and Athira Pharma’s (ATHA) 200-day simple moving average is 2.14, creating a Sell signal.

Athira Pharma (ATHA) Technical Indicators

Nov 26, 2024, 05:07 PM
Name
Value
Implied Action
RSI (14)
48.53
Neutral
STOCH (9,6)
15.25
Buy
STOCHRSI (14)
22.21
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
31.80
Neutral
Williams %R
-87.11
Buy
CCI (14)
-14.40
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
40.25
Neutral
ROC
-16.00
Sell
Athira Pharma’s (ATHA) Relative Strength Index (RSI) is 48.53, creating a Neutral signal.
Athira Pharma’s (ATHA) Trend Strength Indicator (ADX) is 31.80, creating a Neutral signal.
Athira Pharma’s (ATHA) Commodity Channel Index (CCI) is -14.40, creating a Neutral signal.
Athira Pharma’s (ATHA) Price Rate of Change (ROC) is -16.00, creating a Sell signal.

FAQ

Is ATHA a Buy, Hold, or Sell?
Based on ATHA’s technical indicators, ATHA is a Strong Sell.
    What is ATHA’s RSI (14)?
    ATHA’s RSI (14) is 48.53, which suggests ATHA is a Neutral.
      What is ATHA’s MACD?
      ATHA’s MACD is <0.01, which suggests ATHA is a Sell.
        What is ATHA’s 5-day moving average?
        ATHA’s 5-day moving average is 0.64, which suggests ATHA is a Sell.
          What is ATHA’s 20-day moving average?
          ATHA 20-day moving average is 0.64, which suggests ATHA is a Sell.
            What is ATHA’s 50-day moving average?
            ATHA’s 50-day moving average is 0.53, which suggests ATHA is a Buy.
              What is ATHA’s 200-day moving average?
              ATHA’s 200-day moving average is 2.14, which suggests ATHA is a Sell.
                What is ATHA’s Williams % R (14)?
                ATHA’s Williams % R (14) is -87.11, which suggests ATHA is a Buy.
                  What is ATHA’s CCI (14)?
                  ATHA’s CCI (14) is -14.40, which suggests ATHA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis